Quantinno Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Quantinno Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.36M	Buy	19,892 +4,939	+33%	+$845K	0.01%	1328
2025 Q4	$2.52M	Buy	14,953 +8,871	+146%	+$1.44M	0.01%	1284
2025 Q3	$878K	Buy	6,082 +1,764	+41%	+$241K	﹤0.01%	1570
2025 Q2	$546K	Buy	4,318 +2,454	+132%	+$301K	﹤0.01%	1598
2025 Q1	$238K	Buy	+1,864	New	+$253K	﹤0.01%	1756
2024 Q4	–	Sell	-1,679	Closed	-$244K	–	1661
2024 Q3	$244K	Buy	+1,679	New	+$243K	﹤0.01%	1333

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Quantinno Capital Management's IBB Position: Q1 2026 in Review

Quantinno Capital Management increased its iShares Biotechnology ETF (IBB) stake by 33% in Q1 2026, buying an estimated $845K and bringing the position to 19,892 shares worth $3.36M. The position accounts for 0.01% of the portfolio, ranked #1328.

Quantinno Capital Management first reported a position in IBB in Q3 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Quantinno Capital Management held 19,892 shares of iShares Biotechnology ETF worth $3.36M as of Q1 2026.
Quantinno Capital Management bought 4,939 iShares Biotechnology ETF shares in Q1 2026, an estimated $845K.
iShares Biotechnology ETF made up 0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #1328 holding.
Quantinno Capital Management first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 6 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.